We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
176
Boston Scientific
BSX
$68.5B
$48.1M 0.12%
2,224,009
+71,233
+3% +$1.55M
EQR icon
177
Equity Residential
EQR
$25.5B
$47.3M 0.12%
734,602
+54,459
+8% +$3.35M
REGN icon
178
Regeneron Pharmaceuticals
REGN
$72.9B
$47.1M 0.12%
128,308
+2,179
+2% +$829K
ADM icon
179
Archer Daniels Midland
ADM
$40.1B
$47M 0.12%
1,030,434
+58,115
+6% +$2.57M
SYF icon
180
Synchrony
SYF
$25.1B
$47M 0.12%
1,294,897
+103,430
+9% +$3.3M
ISRG icon
181
Intuitive Surgical
ISRG
$130B
$46.8M 0.12%
664,110
+39,510
+6% +$2.9M
SPGI icon
182
S&P Global
SPGI
$125B
$46.6M 0.12%
433,495
+11,155
+3% +$1.33M
INTU icon
183
Intuit
INTU
$85.6B
$46.3M 0.12%
403,781
+13,862
+4% +$1.55M
ALXN
184
DELISTED
Alexion Pharmaceuticals
ALXN
$46.1M 0.12%
376,594
+14,255
+4% +$1.74M
WELL icon
185
Welltower
WELL
$175B
$45.8M 0.12%
683,701
+100,786
+17% +$6.68M
STZ icon
186
Constellation Brands
STZ
$22.5B
$45.3M 0.11%
295,737
+15,458
+6% +$2.46M
LYB icon
187
LyondellBasell Industries
LYB
$18.8B
$45.3M 0.11%
528,084
+19,503
+4% +$1.64M
FISV
188
Fiserv Inc
FISV
$28.9B
$45.2M 0.11%
851,412
+47,608
+6% +$2.45M
AZO icon
189
AutoZone
AZO
$50.9B
$45.2M 0.11%
57,241
+3,705
+7% +$2.85M
SRE icon
190
Sempra
SRE
$59.2B
$45.2M 0.11%
898,416
+77,880
+9% +$3.96M
MPC icon
191
Marathon Petroleum
MPC
$89.3B
$45.1M 0.11%
895,049
+74,350
+9% +$3.38M
CMI icon
192
Cummins
CMI
$88.5B
$45M 0.11%
329,208
+38,501
+13% +$5.15M
AVB icon
193
AvalonBay Communities
AVB
$27.2B
$44.7M 0.11%
252,480
+28,680
+13% +$4.83M
PAYX icon
194
Paychex
PAYX
$42.3B
$43.6M 0.11%
716,593
+46,967
+7% +$2.71M
HPQ icon
195
HP
HPQ
$25.9B
$43M 0.11%
2,897,641
+113,709
+4% +$1.72M
APH icon
196
Amphenol
APH
$177B
$42.9M 0.11%
2,554,580
+203,884
+9% +$3.4M
VTR icon
197
Ventas
VTR
$47.7B
$42.9M 0.11%
685,550
+92,220
+16% +$5.84M
WY icon
198
Weyerhaeuser
WY
$17.7B
$42.6M 0.11%
1,414,474
+136,070
+11% +$4.19M
EA icon
199
Electronic Arts
EA
$52.4B
$42.5M 0.11%
539,197
+33,778
+7% +$2.72M
MTB icon
200
M&T Bank
MTB
$36.6B
$41.5M 0.11%
265,196
+30,975
+13% +$4.19M

Similar funds

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.